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Pulmonary involvement in chronic lymphocytic leukemia (CLL) has been previously described
and is usually characterized by lymphocytic infiltration in the peribronchial interstitium. Endo-
bronchial involvement is a very rare pulmonary manifestation of CLL unless a transformation to
high-grade lymphoma occurs. In the present case we describe an elderly patient with indolent
CLL in whom endobronchial involvement led to severe acute respiratory failure.
ª 2008 Elsevier Ltd. All rights reserved.Chronic lymphocytic leukemia (CLL) is a monoclonal
disorder characterized by a progressive accumulation of
functionally incompetent lymphocytes, and is the most
common form of leukemia found in adults in Western
countries.1 Pulmonary parenchymal involvement in CLL
has been previously described and is characterized by
lymphocytic infiltration in the peribronchial and peri-
vascular interstitium. On the other hand, endobronchial
involvement is a very rare pulmonary manifestation of
CLL unless a transformation to high-grade lymphoma
occurs.2972 48542321; fax: þ972
@rambam.hea l th .gov. i l
ll rights reserved.In the present case we describe an elderly patient with
indolent CLL in whom endobronchial involvement led to
severe acute respiratory failure.
The patient is a 79-year-old female with CLL that was
diagnosed in 2006 based on cervical lymph node biopsy.
Upon presentation her white-blood cell (WBC) count was
25.4 109/L with 70% lymphocytes, hemoglobin 14.7 g/dL,
and platelet count 228 109/L. Since she was a symptom-
atic apart from mild cervical lymphadenopathy no treat-
ment was advised at that time.
The patient was referred on February 2008 with a 1-
week history of new nonproductive cough and dyspnea on
effort.
On physical examination, the patient had temperature
of 37.2

C, heart rate of 112 beats/min, and blood pressure
of 125/60 mmHg. Her respiratory rate was 26 breaths/min,
Figure 2 Chest computed tomography of the chest at
the level of the main carina demonstrating partial collapse of
the left upper lobe (LUL) secondary to endobronchial mass
in the LUL bronchus.
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inspiratory and expiratory wheezes were heard upon lung
auscultation. Initial laboratory data revealed WBC count of
10.2 109/L with 45% lymphocytes, hemoglobin 11.5 g/dL,
and platelet count 130 109/L. Chest radiograph on
admission (Fig. 1) revealed complete collapse of the left
upper lobe (LUL), that was confirmed by a CT scan of the
chest (Fig. 2) that demonstrated a large LUL mass suspi-
cious of tumor infiltration or collapse secondary to
obstruction of the LUL bronchus. The patient underwent
fiberoptic bronchoscopy (FOB) under conscious sedation
using midazolam. FOB revealed diffuse infiltration of LUL
and right middle lobe bronchi. The mucosal surface of the
bronchi was hyperemic and easily bleeding upon contact
with fragile necrotic debris. The LUL broncus was nearly
totally occluded by endobronchial tumor lesion. Six endo-
bronchial biopsies were taken from the obstructing lesion in
the LUL bronchus and lavage fluid was taken for cytological
examination. Forty-eight hours following FOB the patient’s
respiratory status worsened and she was intubated and
mechanically ventilated due to severe hypoxemic respira-
tory failure.
Cytologic examination of lavage fluid revealed many
atypical lymphocytes highly suspicious for lymphoma,
cultures were negative. Based upon these preliminary
results intravenous (I.V.) dexamethasone 20 mg/d was
administrated. Three days later, histopathological exami-
nation of endobronchial biopsies revealed bronchial wall
infiltrated by small lymphocytic malignant lymphoma
(Fig. 3). The cells were positive for: CD20, CD79A, CD5,
CD23, and CD43, and negative for CD10. The proliferation
index was 30%. Upon confirmation of the pathological
results the patient was given in addition to I.V. dexa-
methasone, I.V. Vincristine 1.7 mg and I.V. Cyclophospha-
mide 910 mg. In addition, aggressive hydration was given to
prevent tumor lysis syndrome. Despite initiating chemo-
therapy, the patient’s respiratory condition did notFigure 1 Posteroanterior radiograph of the chest showing
left upper lobe collapse.improve, and she remained mechanically ventilated
through permanent tracheostomy and subsequently trans-
ferred to a long-term respiratory care center.
Discussion
Endobronchial involvement occurs rarely in lymphoma,
mostly in the setting of systemic disease and much more
often in Hodgkin’s disease than in non-Hodgkin’s lymphoma
(NHL).2 A series of case reports of endobronchial NHL
describes four patients all were known to have dissemi-
nated NHL when endobronchial involvement was diag-
nosed.3 In a previous report, we described eight cases of
NHL presenting as an endobronchial tumor, out of whom six
had diffuse large cell lymphoma.4
Endobronchial lymphoma is classified into two types,
according to pattern of involvement. Type I includes diffuse
sub-mucosal infiltrates originating from hematogenous or
lymphangitic spread in the presence of systemic lymphoma
as in our patient. Type II includes airway involvement byFigure 3 Endobronchial biopsy (hematoxylin and eosin
stain). Medium power magnification of the bronchial mucosa
covered by respiratory epithelium. The stroma shows diffuse
infiltration by many small lymphocytes (chronic lymphocytic
leukemia).
Endobronchial obstruction resulting in severe respiratory failure 243a localized mass due to direct spread of lymphoma from
adjacent lymph nodes or arising de novo from bronchus-
associated lymphoid tissue (BALT).
Pulmonary parenchymal involvement in CLL has been
well described and is characterized by lymphocytic infil-
trates in the peribronchial and perivascular interstitium.
Lymphocytes can also be seen infiltrating the alveolar walls
and septa. These changes are reported to occur in
approximately one-third of patients with CLL, and are
usually asymptomatic and discovered only at autopsy.5
Endobronchial disease, on the other hand, is a very rare
manifestation of CLL. Previous report described two
patients with CLL in whom Richter’s syndrome developed
and bronchial obstruction occurred due to massive peri-
bronchial lymphadenopathy and endobronchial leukemic
infiltrates. The endobronchial involvement was of high-
grade lymphoma cells.6
In our case, on the other hand, the bulky endobronchial
involvement was due to CLL cells (low grade lymphoma)
and not high-grade malignant lymphoma cells as in Rich-
ter’s syndrome. Hence we suggest that bronchial involve-
ment should therefore be suspected even in patients with
indolent CLL who present with cough, recurrent pneumo-
nias, or atelectasis.
Another case report describes a woman who had been
diagnosed with CLL 15 years before presentation with
recurrent episodes of lingular and left lower lobe infil-
trates.7 The patient was found to have endobronchial nar-
rowing of the lingular bronchus. Biopsy specimens of the
lingular bronchus revealed submucosal infiltration by
malignant lymphocytes of low-grade lymphoma. The
patient was effectively palliated with local irradiation and
prednisone therapy for 18 months. The authors have sug-
gested that the endobronchial infiltrates seen in their
patient were an extension of a peribronchial infiltrative
process. The patient described had relatively mild symp-
toms due to endobronchial involvement including cough
mild dyspnea. The clinical course of our patient is differentfrom the patient described by Chernoff et al. We describe
an aggressive rapid course of pulmonary CLL resulting in
respiratory failure necessitating mechanical ventilation due
to direct endobronchial involvement. Physicians should be
aware of this life-threatening course, recognize it rapidly
by early FOB, and initiate aggressive chemotherapic
therapy as soon as the diagnosis is confirmed pathologically.
Corticosteroids should be administrated after infection has
been ruled out based upon rapid cytological examination of
lavage fluid obtained during FOB.
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